These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 27072979)

  • 1. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development.
    Nagaich U; Gulati N
    Curr Drug Deliv; 2018; 15(5):641-651. PubMed ID: 28925874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
    Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
    Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Process optimization and photostability of silymarin nanostructured lipid carriers: effect on UV-irradiated rat skin and SK-MEL 2 cell line.
    Singh P; Singh M; Kanoujia J; Arya M; Saraf SK; Saraf SA
    Drug Deliv Transl Res; 2016 Oct; 6(5):597-609. PubMed ID: 27431400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructured lipid carriers loaded with Halobetasol propionate for topical treatment of inflammation: Development, characterization, biopharmaceutical behavior and therapeutic efficacy of gel dosage forms.
    Carvajal-Vidal P; González-Pizarro R; Araya C; Espina M; Halbaut L; Gómez de Aranda I; García ML; Calpena AC
    Int J Pharm; 2020 Jul; 585():119480. PubMed ID: 32479897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
    Kaur N; Sharma K; Bedi N
    Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
    Zhao X; Sun Y; Li Z
    Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clobetasol-loaded nanostructured lipid carriers for epidermal targeting.
    Silva LA; Andrade LM; de Sá FA; Marreto RN; Lima EM; Gratieri T; Taveira SF
    J Pharm Pharmacol; 2016 Jun; 68(6):742-50. PubMed ID: 27061573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characteristics of monostearin nanostructured lipid carriers.
    Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
    Int J Pharm; 2006 May; 314(1):83-9. PubMed ID: 16563671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterisation of clobetasol propionate loaded Squarticles as a lipid nanocarrier for treatment of plaque psoriasis.
    Dadwal A; Mishra N; Rawal RK; Narang RK
    J Microencapsul; 2020 Aug; 37(5):341-354. PubMed ID: 32293928
    [No Abstract]   [Full Text] [Related]  

  • 15. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil.
    Rajinikanth PS; Chellian J
    Int J Nanomedicine; 2016; 11():5067-5077. PubMed ID: 27785014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
    Cirri M; Bragagni M; Mennini N; Mura P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carrier-incorporated gel for efficient topical delivery of fluconazole.
    Patil A; Tuencar V; Gadad A; Dandagi P; Masareddy R
    Ther Deliv; 2021 Aug; 12(8):565-574. PubMed ID: 34187177
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 20. Nanostructured lipid carrier (NLC) based gel of celecoxib.
    Joshi M; Patravale V
    Int J Pharm; 2008 Jan; 346(1-2):124-32. PubMed ID: 17651933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.